ANPOLY key facts
- Developer of a non-toxic, biodegradable, and biocompatible biopolymer designed to be used extensively in biomedical applications.
- It has raised $100K; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include Tech Incubator Program for Startup, Korea Development Bank, Enlight Ventures, Posco Investment, Lotte Ventures — 16 tracked in total.
- Status: Privately Held (backing).
Who backs ANPOLY
16+- ·The complete investor list: 16 names
- ·Watch ANPOLY: the Monday email on marks, rounds and moves
ANPOLY funding rounds
No funding rounds for ANPOLY are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
ANPOLY investors
16 investors are on record for ANPOLY, including Tech Incubator Program for Startup, Korea Development Bank, Enlight Ventures and Posco Investment. By type, the record holds 4 venture capital firms and 1 private equity firm.
About ANPOLY
Developer of a non-toxic, biodegradable, and biocompatible biopolymer designed to be used extensively in biomedical applications. The company offers nano-chitin by extracting cellulose from rice husks, which are applied in tissue scaffolds, drug delivery, and wound dressings, enabling companies to replace various synthetic polymers, including plastics.
- Sector
- Materials and Resources
- HQ
- Pohang, South Korea
- Founded
- 2017
- Employees
- 28
- Website
- anpolyinc.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
ANPOLY doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.